Back
 JTR  Vol.4 No.4 , December 2016
Frequency of Depression and Anxiety among Tuberculosis Patients
Abstract: Objective: The aim of present study was to determine the frequency of depression and anxiety among tuberculosis patients. Methods: It was a descriptive study that had investigated the co-morbidity of depression and anxiety among tuberculosis patients with reference to gender. This study was conducted in Jinnah Post Graduate Medical Centre—Chest ward (TB clinic) from July 2014 to September 2014. Hundred diagnosed patients of tuberculosis (50 males and 50 females) were randomly selected. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder Questionnaire (GAD-7) were used to assess the level of anxiety and depression. Results: Findings indicated that 56% tuberculosis (TB) patients had moderate to severe level of depression, whereas 65% TB patients had moderate to severe level of anxiety. Female patients had significantly high prevalence of depression as compared to males (t = 2.173, P < 0.05). Similarly, prevalence of anxiety was also significantly higher in female patients (t = 3.468, P < 0.05). Conclusion: Likelihood of depression and anxiety was frequent in tuberculosis patients. However, better management of these psychiatric morbidities may improve treatment adherence, illness perception and patient coping skills.
Cite this paper: Amreen, &. and Rizvi, N. (2016) Frequency of Depression and Anxiety among Tuberculosis Patients. Journal of Tuberculosis Research, 4, 183-190. doi: 10.4236/jtr.2016.44021.
References

[1]   World Health Organization (2016) WHO Global Tuberculosis Report.
http://www.who.int/tb/publications/global_report/en/

[2]   World Health Organization (2014) Fact Sheet October.
http://www.who.int/mediacentre/factsheets/fs104/en/

[3]   Moonan, P.K., Quitugua, T.N., Pogoda, J.M., Woo, G., Drewyer, G., Sahbazian, B., et al. (2011) Does Directly Observed Therapy (DOT) Reduce Drug Resistant Tuberculosis? BMC Public Health, 2, 11-19.

[4]   Kulkarni, P., Akarte, S., Mankeshwar, R., Bhawalkar, J., Banerjee, A. and Kulkarni, A. (2013) Non-Adherence of New Pulmonary Tuberculosis Patients to Anti-Tuberculosis Treatment. Annals of Medical and Health Sciences Research, 3, 67-74.
https://doi.org/10.4103/2141-9248.109507

[5]   De Muynck, A., Siddiqi, S., Ghaffar, A. and Sadiq, H. (2001) Tuberculosis Control in Pakistan: Critical Analysis of Its Implementation. Journal of the Pakistan Medical Association, 51, 41-47.
http://jpma.org.pk/full_article_text.php?article_id=2497

[6]   Fatima, R., Qadeer, E., Enarson, D.A., Creswell, J., Stevens, R.H., Hinderaker, S.G., et al. (2014) Success of Active Tuberculosis Case Detection among High-Risk Groups in Urban Slums in Pakistan. International Journal of Tuberculosis and Lung Disease, 18, 1099-1104.
https://doi.org/10.5588/ijtld.14.0001
https://www.ncbi.nlm.nih.gov/pubmed/25189559

[7]   Fatima, R., Harris, R.J., Enarson, D.A., Hinderaker, S.G., Qadeer, E., Ali, K., et al. (2014) Estimating Tuberculosis Burden and Case Detection in Pakistan. International Journal of Tuberculosis and Lung Disease, 18, 55-60.
https://doi.org/10.5588/ijtld.13.0198

[8]  
http://ntp.gov.pk/uploads/Annual_Report_2014_NTP_Pakistan.pdf

[9]   Aamir, S. and Aisha (2010) Co-Morbid Anxiety and Depression among Pulmonary Tuberculosis Patients. Journal of the College of Physicians and Surgeons Pakistan, 20, 703-704.

[10]   Pachi, A., Bratis, D., Moussas, G. and Tselebis, A. (2013) Psychiatric Morbidity and Other Factors Affecting Treatment Adherence in Pulmonary Tuberculosis Patients. Tuberculosis Research and Treatment, 37, Article ID: 489865.

[11]   Rubeen, R., Zareen, N., Zameer, S., Rasool, A.G., Naqvi, S.N. and Iqbal, J. (2014) Anxiety and Depression in Tuberculosis Can Create Impact on Quality of Life of Patient. Acta Medical International, 1, 93-98.

[12]   Spitzer, R.L., Kroenke, K. and Williams, J.B. (1999) Validation and Utility of a Self-Report Version of PRIME-MD: The PHQ Primary Care Study. JAMA, 282, 1737-1744.
https://doi.org/10.1001/jama.282.18.1737

[13]   Spitzer, R.L., Kroenke, K., Williams, J.B. and Löwe, B. (2006) A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Archives of Internal Medicine, 166, 1092-1097.
https://doi.org/10.1001/archinte.166.10.1092

[14]   Husain, M.O., Dearman, S.P., Chaudhry, I.B., Rizvi, N. and Waheed, W. (2008) The Relationship between Anxiety, Depression and Illness Perception in Tuberculosis Patients in Pakistan. Clinical Practice and Epidemiology in Mental Health, 4, 4.
https://doi.org/10.1186/1745-0179-4-4

[15]   Mirza, I. and Jenkins, R. (2004) Risk Factors, Prevalence, and Treatment of Anxiety and Depressive Disorders in Pakistan: Systematic Review. BMJ, 328, 794-798.
http://www.ncbi.nlm.nih.gov/pubmed/15070634
https://doi.org/10.1136/bmj.328.7443.794


[16]   Araújo, G.S., Pereira, S.M., Santos, D.N., Marinho, J.M., Rodrigues, L.C. and Barreto, M.L. (2014) Common Mental Disorders Associated with Tuberculosis: A Matched Case-Control Study. PLoS ONE, 9, e99551.
https://doi.org/10.1371/journal.pone.0099551

[17]   Berg, J., Nyamathi, A., Christiani, A., Morisky, D. and Leake, B. (2005) Predictors of Screening Results for Depressive Symptoms among Homeless Adults in Los Angeles with Latent Tuberculosis. Research in Nursing & Health, 28, 220-229.
https://doi.org/10.1002/nur.20074

[18]   Duko, B., Gebeyehu, A. and Ayano, G. (2015) Prevalence and Correlates of Depression and Anxiety among Patients with Tuberculosis at Wolaita Sodo University Hospital and Sodo Health Center, Wolaita Sodo, South Ethiopia, Cross Sectional Study. BMC Psychiatry, 15, 214.
https://doi.org/10.1186/s12888-015-0598-3

[19]   Wang, J.Y., et al. (2007) The Effect of Smoking on Tuberculosis: Different Patterns and Poorer Outcomes. International Journal of Tuberculosis and Lung Disease, 11, 143-149.
https://www.ncbi.nlm.nih.gov/pubmed/17263283

[20]   Rehm, J., et al. (2009) The Association between Alcohol Use, Alcohol Use Disorders and Tuberculosis (TB). A Systematic Review. BMC Public Health, 9, 450.
https://doi.org/10.1186/1471-2458-9-450

[21]   Arbex, M.A., Varella, M.C.L., Siqueira, H.R. and Mello, F.A.F. (2010) Antituberculosis Drugs: Drug Interactions, Adverse Effects, and Use in Special Situations. Part 2: Second-Line Drugs. Jornal Brasileiro de Pneumologia, 36, 641-656.
https://doi.org/10.1590/S1806-37132010000500017

[22]   Hsu, C.W., Chu, K.A., Lu, T., Lai, R.S. and Lu, J.Y. (1999) Ethambutol-Induced Psychosis: A Case Report. Chinese Medical Journal (Taipei), 62, 724-727.

[23]   Saqbakken, M., Frich, J.C. and Bjune, G. (2008) Barriers and Enablers in the Management of Tuberculosis Treatment in Addis Ababa, Ethiopia: A Qualitative Study. BMC Public Health, 8, 11.
https://doi.org/10.1186/1471-2458-8-11

[24]   Watson, K.T., Roberts, N.M. and Saunders, M.R. (2012) Factors Associated with Anxiety and Depression among African American and White Women. ISRN Psychiatry, 2012, Article ID: 432321.
https://doi.org/10.5402/2012/432321

[25]   NTP National TB Control Program (2012) National Guideline for Programmatic Management of Drug Resistance Tuberculosis (PMDT). 2nd Edition.

 
 
Top